Zobrazeno 1 - 10
of 318
pro vyhledávání: '"Gastrointestinal Diseases/etiology"'
Publikováno v:
Einstein (São Paulo), Vol 18 (2020)
ABSTRACT The new coronavirus disease pandemic is defining 2020, with almost 17.5 million infected individuals and 700 thousand deaths up to beginning of August. It is caused by SARS-CoV-2 and the transmission is through the respiratory tract. Those i
Externí odkaz:
https://doaj.org/article/b86f78418ed443f3a6d9b09caa2113b9
Publikováno v:
Einstein (São Paulo), Vol 18 (2020)
ABSTRACT Coronavirus disease 2019 (COVID-19) is a disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which has spread globally in pandemic proportions. Accumulative evidence suggests SARS-CoV-2 can be transmitted thro
Externí odkaz:
https://doaj.org/article/e0bff64954ae43bf9619372d5be5f7ad
Publikováno v:
Einstein (São Paulo), Volume: 18, Article number: eRW5909, Published: 13 NOV 2020
The new coronavirus disease pandemic is defining 2020, with almost 17.5 million infected individuals and 700 thousand deaths up to beginning of August. It is caused by SARS-CoV-2 and the transmission is through the respiratory tract. Those infected m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______608::6bd84a12b2fa6c7735ac8444741db3d6
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082020000100408&lng=en&tlng=en
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082020000100408&lng=en&tlng=en
Publikováno v:
Einstein (São Paulo), Volume: 18, Article number: eRW5774, Published: 10 JUL 2020
Coronavirus disease 2019 (COVID-19) is a disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which has spread globally in pandemic proportions. Accumulative evidence suggests SARS-CoV-2 can be transmitted through the d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______608::af69a31e77dc7124d36ce9422169f497
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082020000100405&lng=en&tlng=en
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082020000100405&lng=en&tlng=en
Autor:
Denise Hofman, Urszula Kudla, Mohamad Miqdady, Thi Viet Ha Nguyen, Sofía Morán-Ramos, Yvan Vandenplas
Publikováno v:
Nutrients. 14:974
Functional gastrointestinal disorders (FGIDs) refer to gastrointestinal tract issues that lack clear structural or biochemical causes. Their pathophysiology is still unclear, but gut microbiota alterations are thought to play an important role. This
Autor:
Daniel Lam Cham Kee, Daniel Chevallier, Marie-Eve Chand, Jean-Michel Hannoun-Levi, Sylvain Demontoy, Emmanuel Chamorey, Sara Zaki, David Azria, Mathieu Gautier, Alexander T. Falk
Publikováno v:
Brachytherapy
Brachytherapy, Elsevier, 2017, 16 (5), pp.993-999. ⟨10.1016/j.brachy.2017.06.013⟩
Brachytherapy, Elsevier, 2017, 16 (5), pp.993-999. ⟨10.1016/j.brachy.2017.06.013⟩
Purpose Dose escalation for prostate cancer can be achieved with a combination of external beam radiotherapy (EBRT) and brachytherapy (BT) boost to increase local control. For high-dose-rate (HDR)-BT, optimal fractionation remains under debate. The o
Autor:
Dušanka Martinović Kaliterna
Publikováno v:
Reumatizam
Volume 64
Issue suppl. 1
Volume 64
Issue suppl. 1
Sistemska skleroza (SSc) ubraja se u autoimunosne bolesti vezivnog tkiva. Obilježena je obliterativnim i proliferativnim mikrovaskularnim zbivanjima, aktivacijom imunosnog sustava i ekcesivnom fi brozom tkiva i organa. Istražuje se mogući genetski
Autor:
Roberto Alonzi, Peter Hoskin, Ana M. Rojas, Peter Ostler, Linda Bryant, Robert Hughes, Gerry Lowe
Publikováno v:
Hoskin, P, Rojas, A, Ostler, P, Hughes, R, Alonzi, R, Lowe, G & Bryant, L 2014, ' High-dose-rate brachytherapy alone given as two or one fraction to patients for locally advanced prostate cancer : acute toxicity ', Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, vol. 110, no. 2, pp. 268-71 . https://doi.org/10.1016/j.radonc.2013.09.025
BACKGROUND: To evaluate early urinary (GU) and gastrointestinal (GI) adverse events (AEs) after two or one fraction of high-dose rate brachytherapy (HDR-BT) in advanced prostate cancer.PATIENTS AND METHODS: 165 patients were treated with 2 × 13 Gy (
Autor:
Luisa Bordeje, M., Montejo, Juan C., Lidon Mateu, M., Solera, Manuel, Acosta, Jose A., Juan, Mar, Garcia-Cordoba, Francisco, Garcia-Martinez, Miguel A., Gastaldo, Rosa, Acosta, Jose, Albert, Inmaculada, Alec, Alfonso, Luisa Bordeje, Ma, Calvo, Enrique, Ferre, Merce, Garcia de Lorenzo, Abelardo, Angel Garcia-Martinez, Miguel, Gonzalez-Iglesias, Carlos, Iglesias, Rayden, Lorencio, Carol, Martinez de la Gandara, Amalia, Lidon Mateu, Ma, Mesejo, Alfonso, Martinez-Garcia, Pilar, Carlos Montejo, Juan, Luisa Navarrete, Ma, Ortiz-Leyba, Carlos, Robles, Angel, Sanchez-Alvarez, Carmen, Vaquerizo, Clara, Vila, Belen, Carlos Yebenes, Juan, Zabarte, Mercedes, PIANE STUDY GRP SPAIN
Publikováno v:
Nutrients, Vol 11, Iss 11, p 2616 (2019)
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Nutrients
Volume 11
Issue 11
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Nutrients
Volume 11
Issue 11
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
To determine whether elevated intra-abdominal pressure (IAP) is associated with a higher rate of enteral nutrition-related gastrointestinal (GI) complications
to assess the value of IAP as a predictor of enteral nutrition (EN) intolerance. Inten
to assess the value of IAP as a predictor of enteral nutrition (EN) intolerance. Inten
Autor:
William J. Snape Jr
In their second year in medical school, students begin to learn about the differences between'disease'and'illness.'In their studies of pathology they learn to understand disease as pertubations of molecular biological events. And we clinicians can sh